DSIJ Mindshare

Aurobindo Pharma has informed the exchanges on receiving final approval from the US Food & Drug Administration (USFDA) for Guaifenesin tablets.

Profit after tax in Q2FY20 more than doubled to Rs. 193.8 crore from Rs. 89.5 crore in Q2FY19. Further, the company recorded 222 bps and 778 bps improvement in ROCE and ROE to 26.3 per cent and 22 per cent for Q2FY20 respectively.

Dr Reddy's Laboratories on Wednesday said that it has voluntarily recalled all its Ranitidine medicines from US market due to contamination with probable cancer causing N-Nitrosodimethylamine (NDMA).

In the early act, SGX Nifty can be seen marching higher, with global cues being supportive this morning. Further, bulls will take a sigh of relief from the fact that the IMF sees the Indian economic growth, rebounding to around 7 per cent in the next financial year. However, as the day progresses, all eyes will be on the results of the Assembly election, recently held in Haryana and Maharashtra.

The level of 11,550 is immediate support for the Nifty and a sustainable move below this can create opportunities for further corrections towards 11,450 level. Meanwhile, the level of 11,700-11,715 poses stiff resistance for Nifty on the upside. Stocks in news: GMR Infrastructure, Yes Bank, HCL Technologies, PVR, Hindustan Aeronautics, DHFL.